Correction is being made to submitted "b4 - date of this report" for the initial, which was not late.The correct date was 04/05/2024.The report was submitted on apr 5, 2024 at 13:27:25 edt to fda esg and then did not progress.There were no failures or acknowledgements received.The it team was notified same day.An fda esg ticket 387502 was raised with a reply on apr 10, 2024 from fda esg team stating "please resend these submissions.There was an issue on the gateway when these were sent so they were not processed." the file was resubmitted without any changes and subsequently passed receiving all three acknowledgements.Additional information: d9, h3, h4, h6 and h11: the device was inspected at the regional repair center.The device underwent a visual inspection and functional tests and passed all functional and leak tests.It was found to be within specifications; therefore, the customer allegation was not confirmed.A device history review (dhr) was completed, and no issues were identified.Service history did not indicate anything that could have led to this issue.Should additional relevant information become available, a supplemental report will be submitted.
|